Pierre-henri H. Ducluzeau
Tours, 37000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
TyG-derived anthropometric indices as surrogate markers of insulin resistance compared with the hyperinsulinemic-euglycemic clamp.
Journal: Diabetes & metabolism
Published: June 19, 2026
Testosterone therapy is associated with reduced risk of acute kidney injury, kidney failure with renal replacement therapy, and cardiovascular events in men with diabetes and hypogonadism.
Journal: Cardiovascular diabetology
Published: July 23, 2025
Testosterone therapy and the risk of atrial fibrillation, venous thromboembolism and cardiovascular events in cis men with hypogonadism and trans men.
Journal: European journal of endocrinology
Published: December 11, 2024
Acromegaly: Incidence, patient characteristics and treatment patterns in a 10-year nationwide retrospective hospital cohort study.
Journal: Annales d'endocrinologie
Published: June 06, 2024
The hepatokine FGF21 stopped lipogenesis and reduced testosterone production in mLTC-1 Leydig Cell Line.
Journal: Molecular and cellular endocrinology
Published: March 12, 2024
Concentration of Polycyclic Aromatic Hydrocarbons (PAHs) in Human Serum and Adipose Tissues and Stimulatory Effect of Naphthalene in Adipogenesis in 3T3-L1 Cells.
Journal: International journal of molecular sciences
Published: December 20, 2022
Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study.
Journal: Diabetes & metabolism
Published: August 29, 2022
Last Updated: 09/26/2026